Who owns ELEDON PHARMACEUTICALS INC?
- Ticker: ELDN
- CUSIP Number: 28617k101
Tip: Access positions for across all investors
Analyze quarterly positions in Eledon Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Eledon Pharmaceuticals stock
Who bought or sold ELEDON PHARMACEUTICALS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
BVF | 6.3M | $16M | 0% | Sep 2024 |
|
Armistice Capital | 2.3M | $6.2M | 2% | Jun 2024 |
|
Schonfeld Strategic Advisors | 1.5M | $3.7M | 0% | Sep 2024 |
|
Zimmer Partners | 1.4M | $3.6M | -32% | Sep 2024 |
|
Sphera Funds Management | 1.3M | $3.4M | 100% | Jun 2024 |
|
Vanguard Group | 1.1M | $2.9M | 14% | Jun 2024 |
|
Woodline Partners | 843k | $2.1M | 25% | Sep 2024 |
|
Nantahala Capital Management | 600k | $1.5M | 0% | Sep 2024 |
|
Alyeska Investment Group | 500k | $1.2M | 0% | Sep 2024 |
|
Ensign Peak Advisors | 443k | $1.1M | 0% | Sep 2024 |
|
Geode Capital Management | 378k | $942k | 10% | Sep 2024 |
|
CM Management | 275k | $685k | 72% | Sep 2024 |
|
BlackRock | 216k | $538k | 100% | Sep 2024 |
|
State Street Corporation | 162k | $426k | 261% | Jun 2024 |
|
BlackRock | 155k | $409k | 478% | Jun 2024 |
|
Renaissance Technologies | 136k | $338k | -1% | Sep 2024 |
|
Northern Trust | 92k | $229k | 131% | Sep 2024 |
|
Jmac Enterprises | 58k | $145k | 0% | Sep 2024 |
|
Ingalls & Snyder | 52k | $129k | 0% | Sep 2024 |
|
Dimensional Fund Advisors | 34k | $85k | 13% | Sep 2024 |
|
Bridgeway Capital Management | 33k | $88k | 100% | Jun 2024 |
|
Marco Investment Management | 30k | $76k | 0% | Sep 2024 |
|
Susquehanna International | 20k | $50k | -9% | Sep 2024 |
|
Tower Research Capital | 17k | $45k | 199% | Jun 2024 |
|
Mercer Global Advisors | 17k | $44k | 0% | Jun 2024 |
|
Charles Schwab Investment Management | 15k | $37k | 0% | Sep 2024 |
|
Pathstone Holdings | 13k | $32k | 0% | Sep 2024 |
|
Clarity Capital Partners | 12k | $29k | 100% | Sep 2024 |
|
Bank of America Corporation | 6.8k | $17k | 0% | Sep 2024 |
|
Morgan Stanley | 2.2k | $5.7k | 0% | Jun 2024 |
|
Jpmorgan Chase & Co | 97.00 | $241.995600 | 7% | Sep 2024 |
|